Latest Advances

  • Condition: Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Systemic Vasculitis (AAV)
  • Journal: Arthritis research & therapy
  • Treatment Used: Plasma Exchange (PE)
  • Number of Patients: 964
  • Published —
This study assessed the effectiveness of plasma exchange (removal, treatment, and return or exchange of blood plasma; PE) for patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (inflammation of small vessels; AAV).
  • Condition: Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Autoimmunity reviews
  • Treatment Used: Rituximab
  • Number of Patients: 171
  • Published —
In this study, researchers evaluated the outcomes of using rituximab for the treatment of eosinophilic granulomatosis with polyangiitis.
  • Condition: Anti-Neutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Anti-Cytokine Targeted Therapy
  • Number of Patients: 440
  • Published —
This study tested the safety and efficacy of using anti-cytokine targeted therapy to treat patients with ANCA-associated vasculitis.
  • Condition: Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 0
  • Published —
This article discusses the management of interstitial lung disease in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis.
  • Condition: Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA)
  • Journal: Clinical and experimental rheumatology
  • Treatment Used: Conventional Immunosuppressants
  • Number of Patients: 110
  • Published —
This study described the effectiveness of conventional immunosuppressants in disease control in patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA).
  • Condition: Chronic Eosinophilic Disease
  • Journal: Advances in therapy
  • Treatment Used: Oral Corticosteroid
  • Number of Patients: 1
  • Published —
This case study investigated the outcome of using an oral corticosteroid to treat a patient's chronic eosinophilic disease.
  • Condition: Eosinophilic Granulomatosis with Polyangitis
  • Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
  • Treatment Used: Steroids
  • Number of Patients: 1
  • Published —
This case report describes a patient with polyangitis that develops eosinophilic granulomatosis.
  • Condition: Co-Occurrence of PLA2R-Positive Membranous Nephropathy (PMN) without Crescents, and PR3-Positive Eosinophilic Granulomatosis with Polyangiitis
  • Journal: Clinical nephrology
  • Treatment Used: Glucocorticoid and Cyclophosphamide
  • Number of Patients: 1
  • Published —
This case report describes an adult diagnosed with a co-occurrence of PLA2R-positive membranous nephropathy (kidney disease) without crescents, and PR3-positive eosinophilic granulomatosis with polyangiitis (systemic vasculitis) treated with glucocorticoid and cyclophosphamide.
Showing 1-8 of 8